Supernus Pharmaceuticals
SUPN
SUPN
292 hedge funds and large institutions have $2.15B invested in Supernus Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 101 increasing their positions, 96 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
5% more repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 96
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.61% less ownership
Funds ownership: 108.34% → 107.73% (-0.61%)
Holders
292
Holding in Top 10
1
Calls
$994K
Puts
$235K
Top Buyers
| 1 | +$8.51M | |
| 2 | +$7.54M | |
| 3 | +$6.13M | |
| 4 |
D.E. Shaw & Co
New York
|
+$4.95M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$4.56M |
Top Sellers
| 1 | -$9.4M | |
| 2 | -$9.04M | |
| 3 | -$8.04M | |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
-$8M |
| 5 |
SIMG
Stephens Investment Management Group
Houston,
Texas
|
-$6.51M |